4.8 Article

Sensitive Top-Down Proteomics Analysis of a Low Number of Mammalian Cells Using a Nanodroplet Sample Processing Platform

期刊

ANALYTICAL CHEMISTRY
卷 92, 期 10, 页码 7087-7095

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.0c00467

关键词

-

资金

  1. International Centre for Cancer Vaccine Science
  2. European Union under the European Regional Development Fund
  3. Intramural program at EMSL [grid.436923.9]
  4. DOE Office of Science User Facility - Office of Biological and Environmental Research [DE-AC0576RL01830]
  5. European Union under the European Regional Development Fund [MAB/2017/03]

向作者/读者索取更多资源

Top-down proteomics is a powerful tool for characterizing genetic variations and post-translational modifications at intact protein level. However, one significant technical gap of top-down proteomics is the inability to analyze a low amount of biological samples, which limits its access to isolated rare cells, fine needle aspiration biopsies, and tissue substructures. Herein, we developed an ultrasensitive top-down platform by incorporating a microfluidic sample preparation system, termed nanoPOTS (nanodroplet processing in one pot for trace samples), into a top-down proteomic workflow. A unique combination of a nonionic detergent dodecyl-beta-D-maltopyranoside (DDM) with urea as protein extraction buffer significantly improved both protein extraction efficiency and sample recovery. We hypothesize that the DDM detergent improves protein recovery by efficiently reducing nonspecific adsorption of intact proteins on container surfaces, while urea serves as a strong denaturant to disrupt noncovalent complexes and release intact proteins for downstream analysis. The nanoPOTS-based top-down platform reproducibly and quantitatively identified similar to 170 to similar to 620 proteoforms from similar to 70 to similar to 770 HeLa cells containing similar to 10 to similar to 115 ng of total protein. A variety of post-translational modifications including acetylation, myristoylation, and iron binding were identified using only less than 800 cells. We anticipate the nanoPOTS top-down proteomics platform will be broadly applicable in biomedical research, particularly where clinical specimens are not available in amounts amenable to standard workflows.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据